JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2092327, encodeId=7bd2209232e23, content=纯生信，投稿之后20天了一直显示6 Reviewer(s) invited。要写信问一下嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf758287370, createdName=ms1000000773147608, createdTime=Fri Oct 07 18:06:28 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159590, encodeId=7bc121595901e, content=9月的editor appointed今天又退回邀请5个审稿人了（显示月份是以前的7月），什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f88660443, createdName=ms1000000718384293, createdTime=Mon Sep 25 14:20:08 CST 2023, time=2023-09-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103781, encodeId=ea8d2103e8194, content=友友们，这个杂志在送审之后被拒的几率大吗，等待编辑决定中，好忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221012/58d49d92e28d4e819acde854b28c54f3/2d209f1b3c1c49a69e36f6b2ebb7804f.jpeg, createdBy=b5d25455370, createdName=ms1000001786385695, createdTime=Thu Dec 01 21:12:28 CST 2022, time=2022-12-01, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=973497, encodeId=8b229e349704, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：审稿效率比较高，审稿人的意见非常详细有用，虽然直接拒稿率高，但修改后接收概率比较大 下面是审稿记录： New Submission 06 Mar 2021 Under review 1 Apr 2021 Major revisions needed 26 Apr 2021 Revision Submitted 14 May 2021 Under Review 20 May 2018 Reviews Completed 8 Jun 2018 Editor Assigned 12 Jun 2018 Accept 14 Jun 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/124ebe56b3cd429091e32db5a599dcdb/f14a131efc41443381dce9548aa48cc6.jpg, createdBy=9d845414590, createdName=SUTENT, createdTime=Mon Jun 14 17:30:59 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601979, encodeId=e6fa6019e9c4, content=稿件号已经排到2500对多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYLPAlGUWic4ycJwqV0I6tibATcGcbZibzCqfBEe6cmB9RVzqlVFyicicR3kDvDUXMkMZD9OXjtFmtvKg/132, createdBy=072a2537149, createdName=小小小小医生, createdTime=Wed Jun 10 17:07:44 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2022-10-07 ms1000000773147608

纯生信，投稿之后20天了一直显示6 Reviewer(s) invited。要写信问一下嘛？

44 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092327, encodeId=7bd2209232e23, content=纯生信，投稿之后20天了一直显示6 Reviewer(s) invited。要写信问一下嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf758287370, createdName=ms1000000773147608, createdTime=Fri Oct 07 18:06:28 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159590, encodeId=7bc121595901e, content=9月的editor appointed今天又退回邀请5个审稿人了（显示月份是以前的7月），什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f88660443, createdName=ms1000000718384293, createdTime=Mon Sep 25 14:20:08 CST 2023, time=2023-09-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103781, encodeId=ea8d2103e8194, content=友友们，这个杂志在送审之后被拒的几率大吗，等待编辑决定中，好忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221012/58d49d92e28d4e819acde854b28c54f3/2d209f1b3c1c49a69e36f6b2ebb7804f.jpeg, createdBy=b5d25455370, createdName=ms1000001786385695, createdTime=Thu Dec 01 21:12:28 CST 2022, time=2022-12-01, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=973497, encodeId=8b229e349704, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：审稿效率比较高，审稿人的意见非常详细有用，虽然直接拒稿率高，但修改后接收概率比较大 下面是审稿记录： New Submission 06 Mar 2021 Under review 1 Apr 2021 Major revisions needed 26 Apr 2021 Revision Submitted 14 May 2021 Under Review 20 May 2018 Reviews Completed 8 Jun 2018 Editor Assigned 12 Jun 2018 Accept 14 Jun 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/124ebe56b3cd429091e32db5a599dcdb/f14a131efc41443381dce9548aa48cc6.jpg, createdBy=9d845414590, createdName=SUTENT, createdTime=Mon Jun 14 17:30:59 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601979, encodeId=e6fa6019e9c4, content=稿件号已经排到2500对多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYLPAlGUWic4ycJwqV0I6tibATcGcbZibzCqfBEe6cmB9RVzqlVFyicicR3kDvDUXMkMZD9OXjtFmtvKg/132, createdBy=072a2537149, createdName=小小小小医生, createdTime=Wed Jun 10 17:07:44 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2023-09-25 ms1000000718384293 来自河南省

9月的editor appointed今天又退回邀请5个审稿人了（显示月份是以前的7月），什么情况

28 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092327, encodeId=7bd2209232e23, content=纯生信，投稿之后20天了一直显示6 Reviewer(s) invited。要写信问一下嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf758287370, createdName=ms1000000773147608, createdTime=Fri Oct 07 18:06:28 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159590, encodeId=7bc121595901e, content=9月的editor appointed今天又退回邀请5个审稿人了（显示月份是以前的7月），什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f88660443, createdName=ms1000000718384293, createdTime=Mon Sep 25 14:20:08 CST 2023, time=2023-09-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103781, encodeId=ea8d2103e8194, content=友友们，这个杂志在送审之后被拒的几率大吗，等待编辑决定中，好忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221012/58d49d92e28d4e819acde854b28c54f3/2d209f1b3c1c49a69e36f6b2ebb7804f.jpeg, createdBy=b5d25455370, createdName=ms1000001786385695, createdTime=Thu Dec 01 21:12:28 CST 2022, time=2022-12-01, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=973497, encodeId=8b229e349704, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：审稿效率比较高，审稿人的意见非常详细有用，虽然直接拒稿率高，但修改后接收概率比较大 下面是审稿记录： New Submission 06 Mar 2021 Under review 1 Apr 2021 Major revisions needed 26 Apr 2021 Revision Submitted 14 May 2021 Under Review 20 May 2018 Reviews Completed 8 Jun 2018 Editor Assigned 12 Jun 2018 Accept 14 Jun 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/124ebe56b3cd429091e32db5a599dcdb/f14a131efc41443381dce9548aa48cc6.jpg, createdBy=9d845414590, createdName=SUTENT, createdTime=Mon Jun 14 17:30:59 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601979, encodeId=e6fa6019e9c4, content=稿件号已经排到2500对多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYLPAlGUWic4ycJwqV0I6tibATcGcbZibzCqfBEe6cmB9RVzqlVFyicicR3kDvDUXMkMZD9OXjtFmtvKg/132, createdBy=072a2537149, createdName=小小小小医生, createdTime=Wed Jun 10 17:07:44 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2022-11-25 ms7000002055690251 来自东京都

偏重的研究方向：肿瘤
经验分享：11.16 submissions
11.17 Technical check in progress/ ready to be assigned to an editor
11.18 assigned editor
11.24 10 reviewers invited/ two reviewers accepted
11.25 1 Reviewer report received

56 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092327, encodeId=7bd2209232e23, content=纯生信，投稿之后20天了一直显示6 Reviewer(s) invited。要写信问一下嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf758287370, createdName=ms1000000773147608, createdTime=Fri Oct 07 18:06:28 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159590, encodeId=7bc121595901e, content=9月的editor appointed今天又退回邀请5个审稿人了（显示月份是以前的7月），什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f88660443, createdName=ms1000000718384293, createdTime=Mon Sep 25 14:20:08 CST 2023, time=2023-09-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103781, encodeId=ea8d2103e8194, content=友友们，这个杂志在送审之后被拒的几率大吗，等待编辑决定中，好忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221012/58d49d92e28d4e819acde854b28c54f3/2d209f1b3c1c49a69e36f6b2ebb7804f.jpeg, createdBy=b5d25455370, createdName=ms1000001786385695, createdTime=Thu Dec 01 21:12:28 CST 2022, time=2022-12-01, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=973497, encodeId=8b229e349704, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：审稿效率比较高，审稿人的意见非常详细有用，虽然直接拒稿率高，但修改后接收概率比较大 下面是审稿记录： New Submission 06 Mar 2021 Under review 1 Apr 2021 Major revisions needed 26 Apr 2021 Revision Submitted 14 May 2021 Under Review 20 May 2018 Reviews Completed 8 Jun 2018 Editor Assigned 12 Jun 2018 Accept 14 Jun 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/124ebe56b3cd429091e32db5a599dcdb/f14a131efc41443381dce9548aa48cc6.jpg, createdBy=9d845414590, createdName=SUTENT, createdTime=Mon Jun 14 17:30:59 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601979, encodeId=e6fa6019e9c4, content=稿件号已经排到2500对多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYLPAlGUWic4ycJwqV0I6tibATcGcbZibzCqfBEe6cmB9RVzqlVFyicicR3kDvDUXMkMZD9OXjtFmtvKg/132, createdBy=072a2537149, createdName=小小小小医生, createdTime=Wed Jun 10 17:07:44 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2023-10-19 ms3000000403158145 来自河南省

投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？

20 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092327, encodeId=7bd2209232e23, content=纯生信，投稿之后20天了一直显示6 Reviewer(s) invited。要写信问一下嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf758287370, createdName=ms1000000773147608, createdTime=Fri Oct 07 18:06:28 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159590, encodeId=7bc121595901e, content=9月的editor appointed今天又退回邀请5个审稿人了（显示月份是以前的7月），什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f88660443, createdName=ms1000000718384293, createdTime=Mon Sep 25 14:20:08 CST 2023, time=2023-09-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103781, encodeId=ea8d2103e8194, content=友友们，这个杂志在送审之后被拒的几率大吗，等待编辑决定中，好忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221012/58d49d92e28d4e819acde854b28c54f3/2d209f1b3c1c49a69e36f6b2ebb7804f.jpeg, createdBy=b5d25455370, createdName=ms1000001786385695, createdTime=Thu Dec 01 21:12:28 CST 2022, time=2022-12-01, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=973497, encodeId=8b229e349704, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：审稿效率比较高，审稿人的意见非常详细有用，虽然直接拒稿率高，但修改后接收概率比较大 下面是审稿记录： New Submission 06 Mar 2021 Under review 1 Apr 2021 Major revisions needed 26 Apr 2021 Revision Submitted 14 May 2021 Under Review 20 May 2018 Reviews Completed 8 Jun 2018 Editor Assigned 12 Jun 2018 Accept 14 Jun 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/124ebe56b3cd429091e32db5a599dcdb/f14a131efc41443381dce9548aa48cc6.jpg, createdBy=9d845414590, createdName=SUTENT, createdTime=Mon Jun 14 17:30:59 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601979, encodeId=e6fa6019e9c4, content=稿件号已经排到2500对多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYLPAlGUWic4ycJwqV0I6tibATcGcbZibzCqfBEe6cmB9RVzqlVFyicicR3kDvDUXMkMZD9OXjtFmtvKg/132, createdBy=072a2537149, createdName=小小小小医生, createdTime=Wed Jun 10 17:07:44 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2023-04-19 王子安那来自天津

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：临床
经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！

36 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092327, encodeId=7bd2209232e23, content=纯生信，投稿之后20天了一直显示6 Reviewer(s) invited。要写信问一下嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf758287370, createdName=ms1000000773147608, createdTime=Fri Oct 07 18:06:28 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159590, encodeId=7bc121595901e, content=9月的editor appointed今天又退回邀请5个审稿人了（显示月份是以前的7月），什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f88660443, createdName=ms1000000718384293, createdTime=Mon Sep 25 14:20:08 CST 2023, time=2023-09-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103781, encodeId=ea8d2103e8194, content=友友们，这个杂志在送审之后被拒的几率大吗，等待编辑决定中，好忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221012/58d49d92e28d4e819acde854b28c54f3/2d209f1b3c1c49a69e36f6b2ebb7804f.jpeg, createdBy=b5d25455370, createdName=ms1000001786385695, createdTime=Thu Dec 01 21:12:28 CST 2022, time=2022-12-01, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=973497, encodeId=8b229e349704, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：审稿效率比较高，审稿人的意见非常详细有用，虽然直接拒稿率高，但修改后接收概率比较大 下面是审稿记录： New Submission 06 Mar 2021 Under review 1 Apr 2021 Major revisions needed 26 Apr 2021 Revision Submitted 14 May 2021 Under Review 20 May 2018 Reviews Completed 8 Jun 2018 Editor Assigned 12 Jun 2018 Accept 14 Jun 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/124ebe56b3cd429091e32db5a599dcdb/f14a131efc41443381dce9548aa48cc6.jpg, createdBy=9d845414590, createdName=SUTENT, createdTime=Mon Jun 14 17:30:59 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601979, encodeId=e6fa6019e9c4, content=稿件号已经排到2500对多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYLPAlGUWic4ycJwqV0I6tibATcGcbZibzCqfBEe6cmB9RVzqlVFyicicR3kDvDUXMkMZD9OXjtFmtvKg/132, createdBy=072a2537149, createdName=小小小小医生, createdTime=Wed Jun 10 17:07:44 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2023-07-20 小懒emma 来自河南省

快一个月了，还在审稿中，毕业需要，急死了

27 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092327, encodeId=7bd2209232e23, content=纯生信，投稿之后20天了一直显示6 Reviewer(s) invited。要写信问一下嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf758287370, createdName=ms1000000773147608, createdTime=Fri Oct 07 18:06:28 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159590, encodeId=7bc121595901e, content=9月的editor appointed今天又退回邀请5个审稿人了（显示月份是以前的7月），什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f88660443, createdName=ms1000000718384293, createdTime=Mon Sep 25 14:20:08 CST 2023, time=2023-09-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103781, encodeId=ea8d2103e8194, content=友友们，这个杂志在送审之后被拒的几率大吗，等待编辑决定中，好忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221012/58d49d92e28d4e819acde854b28c54f3/2d209f1b3c1c49a69e36f6b2ebb7804f.jpeg, createdBy=b5d25455370, createdName=ms1000001786385695, createdTime=Thu Dec 01 21:12:28 CST 2022, time=2022-12-01, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=973497, encodeId=8b229e349704, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：审稿效率比较高，审稿人的意见非常详细有用，虽然直接拒稿率高，但修改后接收概率比较大 下面是审稿记录： New Submission 06 Mar 2021 Under review 1 Apr 2021 Major revisions needed 26 Apr 2021 Revision Submitted 14 May 2021 Under Review 20 May 2018 Reviews Completed 8 Jun 2018 Editor Assigned 12 Jun 2018 Accept 14 Jun 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/124ebe56b3cd429091e32db5a599dcdb/f14a131efc41443381dce9548aa48cc6.jpg, createdBy=9d845414590, createdName=SUTENT, createdTime=Mon Jun 14 17:30:59 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601979, encodeId=e6fa6019e9c4, content=稿件号已经排到2500对多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYLPAlGUWic4ycJwqV0I6tibATcGcbZibzCqfBEe6cmB9RVzqlVFyicicR3kDvDUXMkMZD9OXjtFmtvKg/132, createdBy=072a2537149, createdName=小小小小医生, createdTime=Wed Jun 10 17:07:44 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2022-12-01 ms1000001786385695 来自甘肃省

友友们，这个杂志在送审之后被拒的几率大吗，等待编辑决定中，好忐忑啊

49 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092327, encodeId=7bd2209232e23, content=纯生信，投稿之后20天了一直显示6 Reviewer(s) invited。要写信问一下嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf758287370, createdName=ms1000000773147608, createdTime=Fri Oct 07 18:06:28 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159590, encodeId=7bc121595901e, content=9月的editor appointed今天又退回邀请5个审稿人了（显示月份是以前的7月），什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f88660443, createdName=ms1000000718384293, createdTime=Mon Sep 25 14:20:08 CST 2023, time=2023-09-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103781, encodeId=ea8d2103e8194, content=友友们，这个杂志在送审之后被拒的几率大吗，等待编辑决定中，好忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221012/58d49d92e28d4e819acde854b28c54f3/2d209f1b3c1c49a69e36f6b2ebb7804f.jpeg, createdBy=b5d25455370, createdName=ms1000001786385695, createdTime=Thu Dec 01 21:12:28 CST 2022, time=2022-12-01, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=973497, encodeId=8b229e349704, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：审稿效率比较高，审稿人的意见非常详细有用，虽然直接拒稿率高，但修改后接收概率比较大 下面是审稿记录： New Submission 06 Mar 2021 Under review 1 Apr 2021 Major revisions needed 26 Apr 2021 Revision Submitted 14 May 2021 Under Review 20 May 2018 Reviews Completed 8 Jun 2018 Editor Assigned 12 Jun 2018 Accept 14 Jun 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/124ebe56b3cd429091e32db5a599dcdb/f14a131efc41443381dce9548aa48cc6.jpg, createdBy=9d845414590, createdName=SUTENT, createdTime=Mon Jun 14 17:30:59 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601979, encodeId=e6fa6019e9c4, content=稿件号已经排到2500对多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYLPAlGUWic4ycJwqV0I6tibATcGcbZibzCqfBEe6cmB9RVzqlVFyicicR3kDvDUXMkMZD9OXjtFmtvKg/132, createdBy=072a2537149, createdName=小小小小医生, createdTime=Wed Jun 10 17:07:44 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2021-06-14 SUTENT

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤学
经验分享：审稿效率比较高，审稿人的意见非常详细有用，虽然直接拒稿率高，但修改后接收概率比较大
下面是审稿记录：
New Submission 06 Mar 2021
Under review 1 Apr 2021
Major revisions needed 26 Apr 2021
Revision Submitted 14 May 2021
Under Review 20 May 2018
Reviews Completed 8 Jun 2018
Editor Assigned 12 Jun 2018
Accept 14 Jun 2021

575 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092327, encodeId=7bd2209232e23, content=纯生信，投稿之后20天了一直显示6 Reviewer(s) invited。要写信问一下嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf758287370, createdName=ms1000000773147608, createdTime=Fri Oct 07 18:06:28 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159590, encodeId=7bc121595901e, content=9月的editor appointed今天又退回邀请5个审稿人了（显示月份是以前的7月），什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f88660443, createdName=ms1000000718384293, createdTime=Mon Sep 25 14:20:08 CST 2023, time=2023-09-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103781, encodeId=ea8d2103e8194, content=友友们，这个杂志在送审之后被拒的几率大吗，等待编辑决定中，好忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221012/58d49d92e28d4e819acde854b28c54f3/2d209f1b3c1c49a69e36f6b2ebb7804f.jpeg, createdBy=b5d25455370, createdName=ms1000001786385695, createdTime=Thu Dec 01 21:12:28 CST 2022, time=2022-12-01, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=973497, encodeId=8b229e349704, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：审稿效率比较高，审稿人的意见非常详细有用，虽然直接拒稿率高，但修改后接收概率比较大 下面是审稿记录： New Submission 06 Mar 2021 Under review 1 Apr 2021 Major revisions needed 26 Apr 2021 Revision Submitted 14 May 2021 Under Review 20 May 2018 Reviews Completed 8 Jun 2018 Editor Assigned 12 Jun 2018 Accept 14 Jun 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/124ebe56b3cd429091e32db5a599dcdb/f14a131efc41443381dce9548aa48cc6.jpg, createdBy=9d845414590, createdName=SUTENT, createdTime=Mon Jun 14 17:30:59 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601979, encodeId=e6fa6019e9c4, content=稿件号已经排到2500对多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYLPAlGUWic4ycJwqV0I6tibATcGcbZibzCqfBEe6cmB9RVzqlVFyicicR3kDvDUXMkMZD9OXjtFmtvKg/132, createdBy=072a2537149, createdName=小小小小医生, createdTime=Wed Jun 10 17:07:44 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2021-10-08 小满爱米粒儿

偏重的研究方向：肿瘤学;THERAPY;肿瘤
经验分享：大佬们，我10.1提交的，现在还在editor assigned

76 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092327, encodeId=7bd2209232e23, content=纯生信，投稿之后20天了一直显示6 Reviewer(s) invited。要写信问一下嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf758287370, createdName=ms1000000773147608, createdTime=Fri Oct 07 18:06:28 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159590, encodeId=7bc121595901e, content=9月的editor appointed今天又退回邀请5个审稿人了（显示月份是以前的7月），什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01f88660443, createdName=ms1000000718384293, createdTime=Mon Sep 25 14:20:08 CST 2023, time=2023-09-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2148975, encodeId=54d021489e5d8, content=快一个月了，还在审稿中，毕业需要，急死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201213/0c5ac7effe254ae4bce0fa2cc2887867/6649319072f04f49b9aaca73a211cec5.jpg, createdBy=9aac2516251, createdName=小懒emma, createdTime=Thu Jul 20 12:01:34 CST 2023, time=2023-07-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2103781, encodeId=ea8d2103e8194, content=友友们，这个杂志在送审之后被拒的几率大吗，等待编辑决定中，好忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221012/58d49d92e28d4e819acde854b28c54f3/2d209f1b3c1c49a69e36f6b2ebb7804f.jpeg, createdBy=b5d25455370, createdName=ms1000001786385695, createdTime=Thu Dec 01 21:12:28 CST 2022, time=2022-12-01, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=973497, encodeId=8b229e349704, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：审稿效率比较高，审稿人的意见非常详细有用，虽然直接拒稿率高，但修改后接收概率比较大 下面是审稿记录： New Submission 06 Mar 2021 Under review 1 Apr 2021 Major revisions needed 26 Apr 2021 Revision Submitted 14 May 2021 Under Review 20 May 2018 Reviews Completed 8 Jun 2018 Editor Assigned 12 Jun 2018 Accept 14 Jun 2021, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=575, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210328/124ebe56b3cd429091e32db5a599dcdb/f14a131efc41443381dce9548aa48cc6.jpg, createdBy=9d845414590, createdName=SUTENT, createdTime=Mon Jun 14 17:30:59 CST 2021, time=2021-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058585, encodeId=484810585850c, content=偏重的研究方向：肿瘤学;THERAPY;肿瘤 经验分享：大佬们，我10.1提交的，现在还在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210316/01c818a509864954848848a9dbd3a97d/253e9da10f88444a8866a1083d453c73.jpg, createdBy=31d51967896, createdName=小满爱米粒儿, createdTime=Fri Oct 08 12:45:51 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601979, encodeId=e6fa6019e9c4, content=稿件号已经排到2500对多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYLPAlGUWic4ycJwqV0I6tibATcGcbZibzCqfBEe6cmB9RVzqlVFyicicR3kDvDUXMkMZD9OXjtFmtvKg/132, createdBy=072a2537149, createdName=小小小小医生, createdTime=Wed Jun 10 17:07:44 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2020-06-10 小小小小医生

稿件号已经排到2500对多了

123 9

展开9条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务